VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$14.48
+0.91 (+6.71%)
As of Mar 29, 10:31 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +139.9% upside
Low Target $25.90
Average Target $34.74
High Target $38.60
Current Price $14.48
Current
$14.48
Target
$34.74
$25.90 $34.74 avg $38.60
Scenario Analysis
Bear Case
$25.90
78.9%
Low target
Base Case
$34.74
+139.9%
Avg target
Bull Case
$38.60
+166.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$65.80
-78.0% from high
52-Week Low
$2.62
+452.7% from low
Target vs 52W High
$34.74
-47.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%